These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 4413316)

  • 1. Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys.
    Harris RT; Waters W; McLendon D
    Psychopharmacologia; 1974 Jun; 37(1):23-9. PubMed ID: 4413316
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge.
    Soler-Cedeno O; Xi ZX
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting the role of CB
    Li X; Hempel BJ; Yang HJ; Han X; Bi GH; Gardner EL; Xi ZX
    Eur Neuropsychopharmacol; 2021 Feb; 43():38-51. PubMed ID: 33334652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicological properties of Δ9-tetrahydrocannabinol and cannabidiol.
    Černe K
    Arh Hig Rada Toksikol; 2020 Mar; 71(1):1-11. PubMed ID: 32597140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precipitated Δ9-THC withdrawal reduces motivation for sucrose reinforcement in mice.
    Eckard ML; Trexler KR; Kotson BT; Anderson KG; Kinsey SG
    Pharmacol Biochem Behav; 2020 Aug; 195():172966. PubMed ID: 32526216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance and dependence to Δ9-tetrahydrocannabinol in rhesus monkeys: Activity assessments.
    Wilkerson JL; Schulze DR; McMahon LR
    PLoS One; 2019; 14(3):e0209947. PubMed ID: 30861005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.
    Panlilio LV; Justinova Z
    Neuropsychopharmacology; 2018 Jan; 43(1):116-141. PubMed ID: 28845848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of footshock stress on place conditioning produced by Δ
    DeVuono MV; Wills KL; MacPherson DV; Hrelja KM; Parker LA
    Psychopharmacology (Berl); 2017 Nov; 234(21):3229-3240. PubMed ID: 28803323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic Pot: Not Your Grandfather's Marijuana.
    Ford BM; Tai S; Fantegrossi WE; Prather PL
    Trends Pharmacol Sci; 2017 Mar; 38(3):257-276. PubMed ID: 28162792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral Determinants of Cannabinoid Self-Administration in Old World Monkeys.
    John WS; Martin TJ; Nader MA
    Neuropsychopharmacology; 2017 Jun; 42(7):1522-1530. PubMed ID: 28059083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Administration of JWH-018 A Synthetic Cannabinoid in Experimentally Naïve Rats.
    Hiranita T
    J Alcohol Drug Depend; 2015 Dec; 3(6):. PubMed ID: 27398395
    [No Abstract]   [Full Text] [Related]  

  • 12. Self-Administration of an Endogenous Cannabinoid 2-Arachidonoylglycerol in Experimentally Naïve Rats.
    Hiranita T
    J Alcohol Drug Depend; 2015 Oct; 3(5):. PubMed ID: 27376099
    [No Abstract]   [Full Text] [Related]  

  • 13. Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg.
    Tanda G
    Psychopharmacology (Berl); 2016 May; 233(10):1845-66. PubMed ID: 27026633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxicity of Synthetic Cannabinoids JWH-081 and JWH-210.
    Cha HJ; Seong YH; Song MJ; Jeong HS; Shin J; Yun J; Han K; Kim YH; Kang H; Kim HS
    Biomol Ther (Seoul); 2015 Nov; 23(6):597-603. PubMed ID: 26535086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future.
    Panagis G; Mackey B; Vlachou S
    Front Psychiatry; 2014; 5():92. PubMed ID: 25132823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?
    Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL
    Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug addiction.
    Justinova Z; Panlilio LV; Goldberg SR
    Curr Top Behav Neurosci; 2009; 1():309-46. PubMed ID: 21104390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs.
    Stewart JL; McMahon LR
    J Pharmacol Exp Ther; 2010 Jul; 334(1):347-56. PubMed ID: 20375197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence.
    Cooper ZD; Haney M
    Int Rev Psychiatry; 2009 Apr; 21(2):104-12. PubMed ID: 19367504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.
    Cooper ZD; Haney M
    Addict Biol; 2008 Jun; 13(2):188-95. PubMed ID: 18279497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.